Insider Transactions in Q1 2025 at Good Rx Holdings, Inc. (GDRX)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 08
2025
|
Romin Nabiey Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,202
-4.97%
|
$20,808
$4.84 P/Share
|
|
Feb 08
2025
|
Romin Nabiey Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,662
+10.79%
|
-
|
|
Jan 21
2025
|
Scott Wagner Director |
BUY
Grant, award, or other acquisition
|
Direct |
28,741
+4.4%
|
-
|
|
Jan 15
2025
|
Romin Nabiey Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,071
-1.15%
|
$4,284
$4.15 P/Share
|
|
Jan 15
2025
|
Romin Nabiey Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,606
+2.72%
|
-
|
|
Jan 08
2025
|
Karsten Voermann Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
29,035
-7.4%
|
$116,140
$4.41 P/Share
|
|
Jan 08
2025
|
Karsten Voermann Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
89,292
+18.53%
|
-
|
|
Jan 01
2025
|
Ronald E Bruehlman Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,653
+24.81%
|
-
|
|
Jan 01
2025
|
Douglas Joseph Hirsch Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,392
+3.98%
|
-
|